Raymond James Financial
IART icon

Raymond James Financial’s Integra LifeSciences IART Stock Holding History

Raymond James Financial’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.52M Buy
267,926
+850
+0.3% +$9.33K ﹤0.01% 3168
2025
Q4 		$3.32M Buy
267,076
+48,599
+22% +$646K ﹤0.01% 2846
2025
Q3 		$3.13M Buy
218,477
+171,286
+363% +$2.35M ﹤0.01% 2820
2025
Q2 		$579K Sell
47,191
-506
-1% -$7.35K ﹤0.01% 3926
2025
Q1 		$1.05M Buy
47,697
+6,105
+15% +$144K ﹤0.01% 3453
2024
Q4 		$943K Buy
+41,592
New +$908K ﹤0.01% 3488

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Raymond James Financial's IART Position: Q1 2026 in Review

Raymond James Financial increased its Integra LifeSciences (IART) stake by 0.32% in Q1 2026, buying an estimated $9.33K and bringing the position to 267,926 shares worth $2.52M. The position accounts for ﹤0.01% of the portfolio, ranked #3168.

Raymond James Financial first reported a position in IART in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.32M in Q4 2025. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Raymond James Financial held 267,926 shares of Integra LifeSciences worth $2.52M as of Q1 2026.
  • Raymond James Financial bought 850 Integra LifeSciences shares in Q1 2026, an estimated $9.33K.
  • Integra LifeSciences made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #3168 holding.
  • Raymond James Financial first reported a position in Integra LifeSciences in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Integra LifeSciences position peaked at $3.32M in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.